Hi Neil,
This move by NEJM Evidence taking up the mantle of the type of information traditionally published by MMWR is especially important given the unfortunate recent conversion of the ProMED service, published by the International Society for Infectious Diseases, to a paid model also [*see note below]. Given the growing threat of infectious disease and other outbreaks (eg, toxicology) around the world due to climate change, conflict, decreasing vaccination coverage, and more, this type of information will become even more important as time goes on and clinicians need rapid access to the latest information on the infectious threats that may be occurring nearby.
cheers,
indi
HIFA profile: Indi Trehan is a physician-scientist and academic researcher based in Seattle, United States. He is a professor of paediatrics at Seattle Children's Hospital; adjunct professor of global health and epidemiology at University of Washington; investigator at UW Global Center for Integrated Health of Women, Adolescents, and Children; and investigator at Seattle Children's Research Institute Center for Clinical and Translational Research. He has published in many different journals, some open, some hybrid, some closed. He has run into the various issues with trying to get funding for open publishing access. He is also an editor at multiple journals and has mentored many junior researchers in both HICs and LMICs on how to navigate open access issues. He is a member of the HIFA Project on Open Access. https://www.hifa.org/support/members/indi indi AT alum.berkeley.edu
[*Note from HIFA moderator (NPW): Thanks Indi. This announcement in 2023 explains the change from ProMED being a free service to a subscription service. https://isid.org/futureofpromed/ Can anyone comment whether this is part of a trend?]